Related Experiment Videos
TGFbeta1 allele association with asthma severity
L J Pulleyn1, R Newton, I M Adcock
1Department of Thoracic Medicine, National Heart and Lung Institute, Imperial College, Dovehouse St, London SW3 6LY, UK.
Human Genetics
|January 26, 2002
Summary
Genetic variations in transforming growth factor beta1 (TGFbeta1) are linked to asthma severity. The C-509T polymorphism, specifically the -509T allele, is a significant marker associated with increased risk in severe asthma patients.
Area of Science:
- Immunology
- Genetics
- Respiratory Medicine
Background:
- Transforming growth factor beta1 (TGFbeta1) is a key cytokine in inflammatory and fibrotic processes.
- Subepithelial fibrosis, linked to airway remodeling, is a hallmark of severe asthma.
- Elevated TGFbeta1 mRNA in eosinophils correlates with asthma severity.
Purpose of the Study:
- To investigate the association between TGFbeta1 gene polymorphisms and asthma severity.
- To identify specific TGFbeta1 variants contributing to the pathogenesis of severe asthma.
Main Methods:
- Genotyping of four TGFbeta1 polymorphisms (C-509T, 72insC, T869C, G915C) in severe asthmatic, mild asthmatic, and control groups.
- Analysis of genotype frequencies and their correlation with asthma severity, steroid usage, and pulmonary function.
Main Results:
- Significant differences in genotype frequencies were observed at the C-509T locus (P=0.016).
- Homozygosity for the -509T allele was more frequent in severe asthmatics compared to mild asthmatics and controls.
- The -509T variant on haplotype 1 emerged as the most informative marker for TGFbeta1's role in asthma severity.
Conclusions:
- The C-509T polymorphism in TGFbeta1 is a potential genetic marker for asthma severity.
- The -509T allele, particularly on haplotype 1, is associated with increased risk and severity of asthma.